Evaluation Results
To maintain the success of the meeting the opinion of the participants of the meeting is essential. In order to receive the necessary feedback as well as to give possible input in next year's program, the participants were asked to fill out an evaluation form to give their ideas on several subjects. The results of the evaluation and the remarks and suggestions will help us to improve the quality of the future workshops.
The overall opinion on the meeting was very positive. The presentation facilities scored highly as well as the time allocated per speaker and session. The interactive character of the meeting was appreciated by the public given the many remarks and questions after each presentation and during the round table sessions. The audience felt even more time for discussion would be welcome.
Scientific Content:
The average scores for the content of the different sessions ranged from 7.4 to 8.2 for the Drug Drug Interaction session (on a scale from 1-10).
88 abstracts were submitted of which 80 abstracts were accepted after review by the Organizing Committee. Of the 80 abstracts, 30 abstracts were orally presented during the meeting.
Logistical Arrangements:
The average scores for the logistical arrangements ranged from 8.0 to 9.2 (on a scale from 1-10)
Meeting venue:
The meeting was held in the 5* Corinthia Grand Hotel Royal in Budapest. This hotel disposes of an ample conference floor with spacious meeting rooms. In order to stimulate an inviting setting for poster viewing, the coffee breaks were located in the poster room. Posters therefore could be viewed during the poster sessions as well as in every free minute and during coffee breaks.
Participants:
Scientific profession:
79 delegates from industry and 112 delegates from academia.
Global distribution:
191 participants from 20 countries attended the meeting: Australia 2, Austria 1, Belgium 5, Canada 26, France 21, Germany 8, Hungary 1, Israel 1, Italy 7, Portugal 9, Servia & Montenegro 1, South Africa 1, Spain 9, Sweden 8, Switzerland 3, Thailand 1, The Netherlands 3, Uganda 1, United Kingdom 24, USA 59.
Coverage of the Meeting:
- Official Meeting report written by Mark Mascolini.
- CLINICAL CARE OPTIONS:
http://clinicaloptions.com/HIV/Conference%20Coverage/Pharmacology%202007.aspx
by Dr. D. Back, and Dr. C. Fletcher (members of the Organizing Committee) - NATAP: http://www.natap.org/2007/pharm/Pharm.htm
one general coverage report by Dr. J. Kiser and Dr. C. Fletcher
7 topic-specific articles by Mark Mascolini
Conclusion:
The Organizing Committee and the Organizing Secretariat are pleased with the outcome of the evaluation and feel that it is justified and necessary to continue the series of international workshops on Clinical Pharmacology of HIV Therapy.
